EU Medical Device Vigilance and Safety Oversight

Regulatory Oversight of the EU Medical Device

Regulatory Oversight of the EU Medical Device

The monitoring of medical device safety in Europe is governed by the Medical Device Regulation (MDR) No. 2017/745 and the In Vitro Diagnostic Medical Device Regulation (IVDR) No. 2017/746. These frameworks require manufacturers of active implantable medical devices (AIMDs), general medical devices (MDs), and In Vitro Diagnostic (IVD) devices to maintain a robust system for post-market surveillance and Field Safety Corrective Actions (FSCAs). Regulatory professionals must remain proactive, as failure to report serious incidents correctly can lead to severe legal and financial consequences.

Criteria for Serious Incident Reporting

Under European regulations, either the manufacturer or their Authorized Representative (AR) is legally obligated to file a serious incident report for any occurrence that involves a device made available on the market.

• Reports are required for incidents involving the death of a patient, user, or any other individual.
• A temporary or permanent serious deterioration in the health of a person must be disclosed.
• Any event posing a serious public health threat must be reported to the competent authority (CA) of the member state where the event happened.

If a manufacturer initiates a recall or FSCA for technical or medical reasons to prevent a serious incident, a report must be distributed to the CAs in every member state where the device is sold.

Mandatory Reporting Timelines

The MDR and IVDR establish strict windows for notifying authorities based on the nature and severity of the event.

• Serious public health threats: Must be reported immediately and no later than 2 days after the manufacturer becomes aware of the threat.
• Death or unanticipated serious deterioration: Notification is required immediately and no later than 10 days after awareness.
• General serious incidents: Must be reported immediately and no later than 15 days after the manufacturer becomes aware.

Administrative Process for Incident and FSCA Reporting

The submission of safety data follows a structured methodology to ensure all relevant authorities are informed of risks and corrective measures.

• Manufacturers must reference MDR Article 87 and IVDR Article 82 to determine the correct reporting timeline based on incident severity.
• A Manufacturer's Incident Report (MIR) form must be completed and submitted to the appropriate CA.
• Manufacturers are required to respond to CA inquiries regarding device design, time on the market, and specific involvement in the incident.
• A determination must be made regarding the necessity of an FSCA and its subsequent reporting to the CAs.
• A final MIR or FSCA report is submitted once the investigation concludes and corrective actions are finalized.
• All vigilance reports and correspondence must be integrated into the company's ISO 13485 or quality management records.

Role of the Authorized Representative

For international manufacturers, the Authorized Representative acts as a vital liaison with European authorities. The AR is responsible for submitting vigilance reports to CAs on behalf of the manufacturer and ensuring that final reports are completed on time with the necessary information for file closure.

Proregulations' EU Vigilance and Incident Services

Our team facilitates compliance with European safety standards through specialized service modules tailored to the latest MDR and IVDR requirements.

• Authorized Representative and CA liaison
  We provide official AR services to manage your mandatory safety notifications and handle all communications with European Competent Authorities.
• Incident reportability and MIR management
  Our experts evaluate potential adverse events to determine reportability and manage the completion and submission of the MIR form.
• FSCA planning and execution support
  We assist in determining when a field action is necessary and manage the distribution of safety notifications across the required European member states.
• Regulatory monitoring and procedure updates
  Our consultants keep your vigilance protocols aligned with the evolving MDCG guidance and member state requirements.
• Technical investigation and documentation alignment
  We ensure that your final safety reports are integrated into your technical files and quality systems to satisfy regulatory audits.

If you are interested in our EU medical device vigilance services and wish to maintain your market access, please feel free to contact us.